Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

BACKGROUND: The aim of this study is to investigate the effect of tumor characteristics and parameters of treatment response in predicting biochemical disease-free survival (BFS) for patients with intermediate or high risk prostate cancer treated by combined definitive external beam radiation therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Geara, Fady B., Bulbul, Muhammad, Khauli, Raja B., Andraos, Therese Y., Abboud, Mirna, Al Mousa, Abdelatif, Sarhan, Nasim, Salem, Ahmed, Ghatasheh, Hamza, Alnsour, Anoud, Ayoub, Zeina, Gheida, Ibrahim Abu, Charafeddine, Maya, Shahait, Mohammed, Shamseddine, Ali, Gheida, Rami Abu, Khader, Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590195/
https://www.ncbi.nlm.nih.gov/pubmed/28882187
http://dx.doi.org/10.1186/s13014-017-0884-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590195/
https://www.ncbi.nlm.nih.gov/pubmed/28882187
http://dx.doi.org/10.1186/s13014-017-0884-y

Ejemplares similares